Algert Global’s Conformis, Inc. Common Stock CFMS Stock Holding History

Algert Global’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-404	Closed	-$12K	–	1105
2021 Q2	$12K	Buy	+404	New	+$9.54K	﹤0.01%	416

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Algert Global's CFMS Position: Q3 2021 in Review

Algert Global sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2021, closing a stake of 404 shares — an estimated $12K sold.

Algert Global first reported a position in CFMS in Q2 2021 and held it in 1 quarter. The position peaked at $12K in Q2 2021. 80 funds tracked by Wall St. Rank hold CFMS as of Q3 2021.

Algert Global reported no remaining Conformis, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Algert Global sold 404 Conformis, Inc. Common Stock shares in Q3 2021, an estimated $12K.
Algert Global first reported a position in Conformis, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Algert Global's Conformis, Inc. Common Stock position peaked at $12K in Q2 2021.
80 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2021.

Based on Algert Global's 13F filing for Q3 2021, filed 15 Nov 2021.